Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Flu2Text: A Multi-Site Study Assessing Text Message Reminders for 2nd Dose of Influenza Vaccine

NCT03287830 is registered in ClinicalTrials.gov with Columbia University as lead sponsor.

NCT NCT03287830
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03287830 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Flu2Text: A Multi-Site Study Assessing Text Message Reminders for 2nd Dose of Influenza Vaccine
Lead sponsor
Columbia University
Phase
Not applicable
Overall status
Completed
Start date
October 6, 2017
Completion date
April 30, 2019
Enrollment
2,105 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

influenza, vaccination